GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Grifols SA ADR GRFS · USD

Health Care · US listing · 🇺🇸 United States

Compare

8.69

+3.08%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$8.34bn

FY2016FY2025

Net income

$445.6m

FY2016FY2025

Free cash flow

$866.9m

FY2016FY2025

Shareholders' equity

$6.08bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$8.34bn$8.32bn$7.61bn$7.00bn$5.69bn$5.34bn$5.10bn$4.49bn$4.32bn$4.05bn
Gross profit$2.98bn$3.23bn$2.87bn$2.55bn$2.27bn$2.26bn$2.34bn$2.05bn$2.15bn$1.91bn
Research and development$413.5m$443.2m$456.2m$416.8m$409.6m$294.2m$276.0m$240.7m$288.3m$197.6m
Operating income$1.37bn$1.21bn$902.9m$903.0m$686.8m$996.1m$1.14bn$994.1m$975.0m$939.4m
Net income$445.6m$181.1m$48.8m$213.5m$217.8m$618.5m$625.1m$596.6m$662.7m$545.5m
Diluted earnings per share0.650.270.070.310.320.910.940.870.970.81

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$22.79bn$24.70bn$24.23bn$24.50bn$22.20bn$15.27bn$17.45bn$12.48bn$10.92bn$10.13bn
Cash and short-term investments$951.7m$1.16bn$745.6m$669.7m$3.10bn$590.5m$2.76bn$1.03bn$886.5m$895.0m
Total liabilities$14.00bn$14.77bn$15.56bn$15.30bn$13.75bn$8.55bn$9.75bn$7.78bn$7.29bn$6.40bn
Debt$9.76bn$10.46bn$10.66bn$10.20bn$9.81bn$6.22bn$358.7m$10.4m$133.1m$203.9m
Shareholders' equity$6.08bn$6.79bn$6.20bn$6.52bn$6.37bn$5.11bn$5.41bn$4.23bn$3.63bn$3.72bn
Shares outstanding681m680m679m679m679m683m664m684m684m675m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$1.16bn$1.04bn$252.4m−$12.5m$689.0m$1.11bn$568.9m$737.4m$841.7m$553.3m
Capital spending−$293.8m−$428.6m−$358.1m−$433.4m−$363.6m−$362.6m−$412.3m−$307.7m−$323.0m−$292.7m
Free cash flow$866.9m$612.6m−$105.7m−$446.0m$325.3m$747.8m$156.6m$429.7m$518.8m$260.6m
Dividends paid−$141.9m−$1.1m—−$683,226−$298.8m−$113.2m−$238.7m−$278.8m−$218.3m−$216.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$2.16bn$1.99bn$2.27bn$2.15bn$2.18bn$2.06bn$2.28bn$2.07bn
Gross profit$812.5m$727.3m$785.2m$867.3m$858.4m$813.2m$884.6m$838.7m
Operating income$379.7m$292.1m$314.2m$442.3m$402.6m$310.3m$429.2m$365.9m
Net income$177.7m$85.6m$112.3m$146.5m$135.1m$68.9m$79.6m$59.7m
Diluted earnings per share0.260.130.170.220.200.100.120.09
Cash from operations$261.0m$129.0m$497.0m$375.0m$179.0m$156.0m$593.0m$345.0m
Capital spending−$137.0m−$61.0m−$154.0m−$80.0m−$69.0m−$56.0m−$115.0m−$97.0m
Free cash flow$124.0m$68.0m$343.0m$295.0m$110.0m$100.0m$478.0m$248.0m
Total assets$23.19bn$23.20bn$22.79bn$22.99bn$22.81bn$24.21bn$24.70bn$23.41bn
Cash and short-term investments$610.5m$811.0m$951.7m$952.7m$653.0m$1.16bn$1.16bn$931.1m
Debt$8.76bn$680.5m$9.76bn$689.0m$9.05bn$758.6m$10.46bn$1.17bn
Shareholders' equity$6.40bn$6.31bn$6.08bn$6.00bn$5.97bn$6.51bn$6.79bn$6.17bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin35.7%38.7%37.7%36.5%39.8%42.2%
Operating margin16.5%14.5%11.0%12.9%11.8%20.6%
Net margin5.3%2.2%0.6%3.1%3.8%11.6%
Return on equity7.3%2.7%0.8%3.3%3.4%12.1%
Return on assets2.0%0.7%0.2%0.9%1.0%4.0%
Free cash flow yield25.6%25.9%10.8%7.4%18.6%29.8%
Revenue growth0.2%9.4%8.7%22.9%-7.6%4.7%
Earnings growth146.1%270.8%-77.1%-2.0%-69.5%-1.1%
Current ratio2.51x2.66x2.64x2.32x1.59x2.37x
Debt to equity1.61x1.54x1.72x1.56x1.54x1.22x
Equity ratio26.7%27.5%25.6%26.6%28.7%33.4%
Interest coverage1.98x1.35x1.40x1.76x2.50x3.87x
R&D as a share of sales5.0%5.3%6.0%6.0%7.2%5.5%
Buybacks as a share of market value-0.0%-0.2%0.0%-0.0%0.6%-3.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.0%9.3%7.8%
Operating income15.0%6.7%3.5%
Net income27.8%-6.3%-1.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin37.2%37.2%38.2%41.3%
Operating margin15.5%14.0%14.4%17.3%
Net margin3.8%2.8%4.1%7.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings14.327.9160.727.035.020.424.721.123.619.9
Price to sales0.80.61.00.81.32.43.02.83.62.7

Market value over time

30 Nov 2016 to 14 Oct 2026, in USD

$10.54bn$4.93bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return20%-29%37%-29%-44%-18%28%-17%40%-2%

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 2 Jul 2026.

FY2026
Paid in the year0.094

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.